NCT07139522View on ClinicalTrials.gov

Dexamethasone Versus Magnesium Sulphate as an Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block for Postoperative Analgesia in Elective Caesarean Section Under Spinal Anesthesia

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
DexamethasoneMagnesium SulphateAdjuvantUltrasoundErector Spinae Plane BlockPostoperative AnalgesiaCesarean SectionSpinal Anesthesia
Interventions
DRUG

Bupivacaine

Patients will receive 20 ml of 0.25% isobaric bupivacaine.

DRUG

Dexamethasone

Patients will receive 20 ml of (0.25% isobaric bupivacaine and 4mg of dexamethasone).

DRUG

Magnesium sulphate

Patients will receive 20 ml of (0.25% isobaric bupivacaine and 200mg of magnesium sulphate).

Trial Locations (1)

12613

RECRUITING

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER